Litcius/Paper detail

Remdesivir for COVID-19 in Europe: will it provide value for money?

Rafael Dal‐Ré, Rita Banzi, Sophie Georgin‐Lavialle, Raphaël Porcher, Reecha Sofat, Markus Zeitlinger, Frits R. Rosendaal

2020The Lancet Respiratory Medicine15 citationsDOIOpen Access PDF

Topics & Concepts

Coronavirus disease 2019 (COVID-19)Medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BetacoronavirusValue (mathematics)Coronavirus InfectionsVirologyPandemicMEDLINEInternal medicineStatisticsLawPolitical scienceDiseaseOutbreakMathematicsInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research
Remdesivir for COVID-19 in Europe: will it provide value for money? | Litcius